Background and Objectives | Time Frame |
---|---|
A global pharmaceutical company wanted to strengthen its portfolio in emerging markets and engaged SmartAnalyst to:
|
20 weeks |
Approach and Recommendations (Methodology) | Results |
A two-phased approach was adopted to identify potential assets for each therapy area (GI, Oncology, and Diabetes)
Phase I: Identification and Shortlisting of Indications and Assets
Phase II: Asset Prioritization
|
Identified opportunities aligned to the client’s strategic needs and created detailed profiles of the prioritized set of assets in GI, Oncology and Diabetes space to inform and support partnering discussions |